Stempoint Capital »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Stempoint Capital

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 209k 63.95

More positions owned by Stempoint Capital

Tango Therapeutics (TNGX)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Erasca (ERAS)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Dianthus Therapeutics (DNTH)
Enliven Therapeutics (ELVN)
Mineralys Therapeutics (MLYS)
Roivant Sciences SHS (ROIV)
Surrozen Com New (SRZN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Scholar Rock Hldg Corp (SRRK)
Alkermes SHS (ALKS)
First Tracks Biotherapeutics Ord Shs (TRAX)

View all positions for Stempoint Capital

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

FMR
Rubric Capital Management
Baker Bros. Advisors
BlackRock
Tang Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Spruce Street Capital
Dimensional Fund Advisors
Invesco
Driehaus Capital Management
Acadian Asset Management
Point72 Asset Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A